Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain · Delayed Price · Currency is EUR 2.720
+0.020 (0.74%)
Aug 27, 2026, 5:35 PM CET
Laboratorio Reig Jofre Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 337.73 | 336.68 | 341.37 | 317.95 | 274.21 | 239.87 |
Revenue Growth | 0.26% | -1.37% | 7.36% | 15.95% | 14.32% | 2.61% |
Gross Profit Gross Profit Growth | 200.71 | 193.2 | 193.45 | 176.89 | 155.09 | 142.97 |
Operating Income Operating Income Growth | 8.91 | 5.7 | 14.73 | 11.99 | 9.37 | 9.28 |
Net Income Net Income Growth | 6.94 | 5.02 | 10.38 | 9.41 | 8.11 | 5.09 |
Earnings Per Share EPS Growth | - | 0.06 | 0.13 | 0.12 | 0.10 | 0.07 |
EPS Growth | - | -52.97% | 8.58% | 17.49% | 52.89% | -6.56% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Specialty Pharmacare Specialty Pharmacare Growth | 120.03 | 115.26 | - | - | - |
Consumer Healthcare Consumer Healthcare Growth | 74.37 | 72.34 | 59.9 | 54.15 | 47.02 |
Sale of Pharmaceutical Products Sale of Pharmaceutical Products Growth | 136.7 | 151.29 | 244.15 | 217 | 189.21 |
Total Total Growth | 331.1 | 338.9 | 316.09 | 271.15 | 236.23 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 15.11 | 17.01 | 16.22 | 6.49 | 6.88 | 5.07 |
Total Debt Total Debt Growth | 119.58 | 93.05 | 59.6 | 54.41 | 61.65 | 68.09 |
Net Cash (Debt) Net Cash Growth | -104.47 | -76.04 | -43.38 | -47.92 | -54.76 | -63.03 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | - | -0.93 | -0.53 | -0.60 | -0.69 | -0.81 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 1.51 | 31.34 | 19.12 | 16.15 | 14.5 |
Capital Expenditures CapEx Growth | - | -15.29 | -20.26 | -12.46 | -10.95 | -19.23 |
Free Cash Flow Free Cash Flow Growth | - | -13.78 | 11.08 | 6.65 | 5.2 | -4.73 |
Free Cash Flow Growth | - | - | 66.51% | 27.90% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 59.43% | 57.38% | 56.67% | 55.63% | 56.56% | 59.60% |
Operating Margin | 2.64% | 1.69% | 4.32% | 3.77% | 3.42% | 3.87% |
Pretax Margin | 2.24% | 1.88% | 3.46% | 3.30% | 3.20% | 2.42% |
Profit Margin | 2.05% | 1.49% | 3.04% | 2.96% | 2.96% | 2.12% |
FCF Margin | - | -4.09% | 3.25% | 2.09% | 1.90% | -1.97% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.049 | - | 0.049 | 0.040 | 0.040 | 0.040 |
Dividend Per Share Growth | -51.02% | - | 22.50% | 0% | 0% | -11.11% |
Dividend Yield | 1.84% | - | 2.01% | 1.84% | 1.91% | 1.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.93 | 41.66 | 19.20 | 18.85 | 20.99 | 49.26 |
Forward PE | 13.60 | 31.15 | 14.65 | 8.91 | 15.93 | 18.11 |
P/FCF Ratio | - | - | 18.00 | 26.65 | 32.72 | - |
PS Ratio | 0.66 | 0.62 | 0.58 | 0.56 | 0.62 | 1.05 |